TANG, Liren,ZHANG, Junling,GUO, Tao,LYLE, Michael Patrick Allen
申请号：
EP17860520
公开号：
EP3526186A4
申请日:
2017.10.04
申请国别(地区):
EP
年份:
2020
代理人:
摘要：
It discloses a compound of formula I that inhibits the activities of numerous of protein kinases involving the signaling of inflammatory cytokines, therefore, the compound can be used for treating cancers, autoimmune diseases and inflammatory diseases.
